FindTrial
Sign In

Monitoring of circulating tumor cell (CTC) in the peripheral blood of patients with small cell lung cancer during treatment with first-line chemotherapy

Monitoring of circulating tumor cell (CTC) in the peripheral blood of patients with small cell lung cancer during treatment with first-line chemotherapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCD-15006054
Enrollment
Unknown
Registered
2015-03-09
Start date
2015-03-09
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small cell lung cancer

Interventions

small cell lung cancer patients:Human Lung Cancer Circulating Tumor Cell Detection Kit

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Histologically or cytologically confirmed locally advanced or advanced SCLC; 2. Patients prepared for First-Line therapy; 3. Normal physiological functions of the viscera as heart, liver, kidney and bone marrow; 4. Life expectancy of at least 3 months; 5. At least one measurable lesion; 6. Age of 18-80 years; 7. CTC counts of more than 8.70 CTC Units in 3mL blood at baseline.

Exclusion criteria

Exclusion criteria: 1. Concurrent other cancers or other serious diseases within 5 years prior to study enrollment; 2. Previous anti-cancer therapy prior to study enrollment; 3. Blood sample collected at unexpected time point; 4. Blood sample with clot condensation; 5. Blood sample of less than 3mL; 6. Blood sample with hematolysis.

Design outcomes

Primary

MeasureTime frame
circulating tumor cell (CTC);—

Countries

China

Contacts

Public ContactCaicun Zhou
caicunzhoudr@163.com+86 21 65115006-3049

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026